The 4 Stages of Heart Failure

Jaski.500.jpg
Jaski.500.jpg
sale

The 4 Stages of Heart Failure

80.10 89.00

Author: Brian E. Jaski

Foreword by Sidney C. Smith, Jr.

Published March 6, 2015

Format: Paperback and eBook set; eBook

Trim size: 6 x 9 inches

ISBN: 9781935395300

336 pages, full color interior

List price: $89  Sale price: $80.10

Print book includes a free digital edition.

Full preview available:  cardiotextpublishing.com/4-stages-look-inside/

In stock. Ships the next business day.

Quantity:
Add To Cart

 

Other Purchasing Options:


About:

If you understand heart failure, you understand cardiology

This book  applies practical clinical concepts to the latest four-stage model of heart failure from preclinical risk and early asymptomatic disease to classic symptomatic heart failure and finally advanced heart failure. This framework emphasizes a tailored approach to ongoing heart failure assessment to guide therapy and improve outcomes.

Features:

  • Illustrated with over 250 full-color figures
  • Specific recommendations backed by clinical trial data
  • Practical algorithms for diagnosis and therapy

Topics include:

  • Prevention of heart failure
  • Identification and treatment of structural heart disease prior to heart failure
  • How to combine lifestyle changes, medications, and devices to improve outcomes
  • Reversing decompensated heart failure
  • Key indicators of advanced heart failure and appropriate treatment options
  • Emerging new therapies

Visit Dr. Brian Jaski's Web site on heart failure for patients: http://www.heartfailure.org/


“This book will be valuable to all training and practicing clinicians. He writes as if you and he are both completing patient rounds together. Brian E. Jaski is to be commended for capturing the essence of treating this formidable clinical challenge and demystifying the stages of heart failure.”

--From the foreword by Sidney C. Smith, Jr. MD FACC, FAHA, FESC, FACP
Professor of Medicine, University of North Carolina at Chapel Hill
Past President, American Heart Association
Past President, World Heart Federation
 

“The culmination of Dr. Jaski’s 25 years of teaching experience and clinical acumen is now available in one highly readable text designed to highlight key information and stimulate the learning process.”

--Dylan E. Wessman, MD, FACC, FACP
Program Director, Cardiovascular Disease Fellowship
Naval Medical Center San Diego
San Diego, California


Author:

Brian E. Jaski, MD, FACC
Director of Clinical Research, San Diego Cardiac Center 
Medical Director Advanced Heart Failure and Cardiac Transplant
Sharp Memorial Hospital
San Diego, California


About the Author:

Dr. Jaski is a clinical physician, researcher, and teacher. After earning undergraduate degrees in electrical engineering and biology at MIT, he graduated from Harvard Medical School where he subsequently finished his cardiology fellowship at the Brigham and Women’s Hospital.  Since 1985, he has been the medical director of the Advanced Heart Failure and Cardiac Transplant program at Sharp Memorial Hospital associated with the San Diego Cardiac Center.  He has published extensively in the areas of cardiac pathophysiology, pharmacology, circulatory support devices, and transplant. He is board certified in the subspecialty of Advanced Heart Failure and Cardiac transplant and webmaster of Heart Failure Online (www.heartfailure.org).


Table of Contents

Chapter 1: Heart Failure Diagnosis and Epidemiology
Heart Failure Recognition
Epidemiology
Hospitalization Admissions and Readmission
Heart Failure Mortality
Costs of Heart Failure

Chapter 2: Heart Failure Presentations and Functional Types
Heart Failure Designation Based On Left Ventricular Systolic Function
Acute and Chronic Presentations of Heart Failure
Common Causes of Heart Failure
Heart Failure Blunts Exercise Capacity
The Role of Biomarkers BNP and NT-proBNP When Heart Failure Is Suspected

Chapter 3: Stage A: Patients at Risk for Developing Structural Heart Disease
Major Risk Factors and Increasing Prevalence of Heart Failure
Treatable Risk Factors for Heart Failure
Goals for the Management of Heart Failure Risk Factors

Chapter 4: Structural Heart Disease and Progression to Failure: Stages B, C, and D
Morphologic Changes in Heart Failure
Patterns of Maladaptive Hypertrophy
Neurohumoral Circulatory Responses
Intracellular Mechanisms of Progression
Gene Mutations in Heart Failure

Chapter 5: Stage B: Asymptomatic Structural Heart Disease
Who Is the Stage B Pre-Heart Failure Patient?
Neurohumoral Continuum from Stage B to Stage C Systolic Dysfunction
The Continuum from Hypertension to HF-pEF
Cardiac and Noncardiac Interactions
Screening Tests for Stage B Heart Failure
Management of Stage B Patients

Chapter 6: Assessment of Stage C Patients with HF-rEF
The 3 “F”s of Ongoing Heart Failure Assessment
Fit: Do Findings Fit the Diagnosis of Heart Failure?
Function: Is Left Ventricular Systolic Function Abnormal by Echocardiography?
Factors: What Are the Etiologies of Heart Failure?
Important Diagnostic Techniques for Heart Failure

Chapter 7: Assessment of Stage C Patients with HF-pEF
Diagnosis of HF-pEF
Management of Hypertrophic Cardiomyopathy
Restrictive Cardiomyopathy Due to Amyloidosis
Additional Causes of Restrictive Cardiomyopathy
Other Important Causes of Heart Failure Syndrome
Valvular Heart Disease
Congenital Heart Disease
Pericardial Disease
Cor Pulmonale
Sleep-Disordered Breathing in Heart Failure

Chapter 8: Stage C: Improving Outcomes in Symptomatic Heart Failure
Evidence-Based Therapies for Patients with HF-rEF
Volume Management with Diuretics
Angiotensin II Inhibition
Beta Adrenoreceptor Blockade
Mineralocorticoid Receptor Antagonists
Neutral Endopeptidase Inhibition
Nitrates and Hydralazine
Digoxin
Electrical Therapies for Heart Failure
Atrial Fibrillation and Heart Failure
Treatment of HF-pEF
Outpatient Hemodynamic Monitoring for Congestion in HF-pEF and HF-rEF Patients

Chapter 9: Stage C: Therapies for Acute Decompensated Heart Failure
Applying The 3 “F”s to Decompensated Heart Failure
Hemodynamic Profiles in Decompensated Heart Failure
Volume Management
Intravenous Vasoactive Drug Therapy and Acute Heart Failure
Comparative Hemodynamic Effects of Intravenous Medications
Mechanical Circulatory Support

Chapter 10: Stage C: Cardiorenal Syndrome
The Cardiorenal Syndrome Definition and Characteristics
Measuring Renal Function
Association of Abnormal GFR and Heart Failure Mortality
Factors Affecting GFR
Management of Heart Failure with Impaired Kidney Function

Chapter 11: Stage D Heart Failure: Options and Opportunities
Who Is the Stage D Heart Failure Patient?
Palliative Care
Cardiac Transplant
Left Ventricular Assist Device (LVAD)
Investigational Therapy

Chapter 12: A Patient-Oriented Perspective to the 4 Stages of Heart Failure
Lifestyle Recommendations
Outpatient Support and Monitoring
Summary of Therapeutic Approaches to the Four Stages of Heart Failure
Concluding Comments


Doody's Review Service 4-Star Rating: